Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000111

Director sold 1 shares at $1,100.03 ($1,100)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Sale : show line 1 in the form 10b5-1 −1 $1,100.03 $1,100 17,782 D
Open-market sales · 1 sh · avg $1,100.03 · $1,100
Loading xslF345X05/edgardoc.xml…